More on ETON

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)
- FDA

Upcoming Events

- Earnings (5/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eton Pharmaceuticals Inc. (NQ:ETON)
Delayed: 16.80 -0.44 (2.55%)
Prev. Close $17.24  
Open$16.92 
52 Wk High$ 
52 Wk Low$ 
Day High$17.25 
Day Low$16.62 
P/E N/A  
EPS$ 
Volume228,781 


Mar 6, 2026 04:06 PM Form S-8 Eton Pharmaceuticals,
Mar 3, 2026 04:30 PM Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Mar 3, 2026 09:20 AM Eton Pharmaceuticals (ETON) PT Raised to $30 at Craig-Hallum
Mar 2, 2026 07:27 AM Eton Pharmaceuticals acquires HEMANGEOL commercialization rights
Mar 2, 2026 07:27 AM Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
Mar 2, 2026 07:01 AM Form 8-K Eton Pharmaceuticals, For: Feb 27
Feb 25, 2026 02:18 PM Form 8-K Eton Pharmaceuticals, For: Feb 25
Feb 25, 2026 01:47 PM Eton Pharmaceuticals receives FDA approval for DESMODA oral solution
Feb 25, 2026 01:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
Feb 20, 2026 06:50 AM Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
View All Articles

Entities mentioned with ETON

View All Entities